MATINAS BIOPHARMA HOLDINGS, INC.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $8.1M | $55.8M | $19.3M |
| Jun 2022 | $9.6M | $52.4M | $10.4M |
| Sep 2022 | $8.9M | $47.5M | $11.2M |
| Dec 2022 | $8.2M | $44.8M | $6.8M |
| Mar 2023 | $5.6M | $38.3M | $5.7M |
| Jun 2023 | $6.2M | $34.0M | $9.7M |
| Sep 2023 | $6.6M | $29.8M | $6.4M |
| Dec 2023 | $5.9M | $25.1M | $4.8M |
| Mar 2024 | $5.1M | $19.6M | $1.1M |
| Jun 2024 | $5.3M | $24.4M | $4.2M |
| Sep 2024 | $4.8M | $20.6M | $10.3M |
| Dec 2024 | $5.1M | $12.6M | $7.3M |
| Mar 2025 | $5.8M | $12.0M | $6.9M |
| Jun 2025 | $3.7M | $11.4M | $6.5M |
| Sep 2025 | $3.2M | $9.7M | $5.4M |
| Dec 2025 | $2.4M | $7.2M | $4.0M |
| Mar 2026 | $2.9M | $5.9M | $2.4M |
| Jun 2026 | $1.6M | $3.4M | $761.0K |